Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists

The application of both structure- and ligand-based design approaches represents to date one of the most useful strategies in the discovery of new drug candidates. In the present paper, we investigated how the application of docking-driven conformational analysis can improve the predictive ability of 3D-QSAR statistical models. With the use of the crystallographic structure in complex with the high affinity antagonist ZM 241385 (4-(2-[7-amino-2-(2-furyl)[1,2,4]-triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol), we revisited a general pharmacophore hypothesis for the human A(2A) adenosine receptor of a set of 751 known antagonists, by applying an integrated ligand- and structure-based approach. Our novel pharmacophore hypothesis has been validated by using an external test set of 29 newly synthesized human adenosine receptor antagonists.

Medienart:

E-Artikel

Erscheinungsjahr:

2013

Erschienen:

2013

Enthalten in:

Zur Gesamtaufnahme - volume:53

Enthalten in:

Journal of chemical information and modeling - 53(2013), 7 vom: 22. Juli, Seite 1620-37

Sprache:

Englisch

Beteiligte Personen:

Bacilieri, Magdalena [VerfasserIn]
Ciancetta, Antonella [VerfasserIn]
Paoletta, Silvia [VerfasserIn]
Federico, Stephanie [VerfasserIn]
Cosconati, Sandro [VerfasserIn]
Cacciari, Barbara [VerfasserIn]
Taliani, Sabrina [VerfasserIn]
Da Settimo, Federico [VerfasserIn]
Novellino, Ettore [VerfasserIn]
Klotz, Karl Norbert [VerfasserIn]
Spalluto, Giampiero [VerfasserIn]
Moro, Stefano [VerfasserIn]

Links:

Volltext

Themen:

Adenosine A2 Receptor Antagonists
Journal Article
Receptor, Adenosine A2A
Research Support, Non-U.S. Gov't
Triazines
Triazoles
ZM 241385

Anmerkungen:

Date Completed 20.02.2014

Date Revised 22.07.2013

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/ci300615u

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM227773853